This multi-receptor profile is structurally and pharmacologically distinct from single-agonist (GLP-1R only, e.g
In response to the hypothyroid state, a compensatory increase in the discharge of central hypothalamic thyrotropin-releasing hormone results in increased stimulation of prolactin secretion.2 Furthermore, prolactin elimination from the systemic circulation is reduced, which contributes to increased prolactin concentrations.2 Primary hypothyroidism can be associated with diffuse pituitary enlargement, which will reverse with appropriate thyroid hormone replacement therapy.2 Pituitary tumours Pituitary tumours are common neoplasms that exhibit a wide range of biological behaviour, as evidenced by hormonal and proliferative activities.2 Among pituitary adenomas, prolactin-producing pituitary tumours are the most common type
Alteration of several metabolic enzymes and pathways that affect KG abundance and KGDD activity have been reported in cancer, such as mutations of IDH1 and IDH2, changes in glutaminolysis that deplete KG, or alterations in fumarate hydratase (FH) and succinate dehydrogenase (SDH) that inhibit KGDD activity (Losman et al., 2020)
Injections seemed invasive, and he wondered how the drug would interact with the other medications he was taking
If you carry genetic variants linked to slower peptide metabolism or variable GLP-1 receptor sensitivity, maintaining medication integrity becomes even more important for accurate response tracking
Chen P, Li B, Ou-Yang L (2022) Role of estrogen receptors in health and disease
